Characteristics associated with specific transition types over a 2-year follow-up period estimated using logistic regression
| CHARACTERISTIC | NO TRANSITIONS (VS ANY TRANSITION OR DEATH) | HOSPITAL ADMISSION OR DEATH (VS NEITHER) | SUPPORTIVE LIVING OR LONG-TERM CARE ADMISSION (VS NO ADMISSION AND ALIVE)* | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | AOR (95% CI) | OR (95% CI) | AOR (95% CI) | OR (95% CI) | AOR (95% CI) | |
| Age, y | ||||||
| • 65-69 | 1 (Ref) | 1 (Ref) | 1 (Ref) | 1 (Ref) | 1 (Ref) | 1 (Ref) |
| • 70-74 | 0.84 (0.42 to 1.69) | 0.84 (0.39 to 1.81) | 1.03 (0.49 to 2.14) | 0.89 (0.41 to 1.94) | 1.19 (0.38 to 3.74) | 1.31 (0.40 to 4.24) |
| • 75-79 | 0.74 (0.39 to 1.40) | 0.81 (0.40 to 1.64) | 1.48 (0.77 to 2.87) | 1.20 (0.60 to 2.40) | 1.66 (0.60 to 4.57) | 1.32 (0.46 to 3.75) |
| • 80-84 | 0.48 (0.26 to 0.89) | 0.51 (0.26 to 1.01) | 2.42 (1.31 to 4.46) | 1.93 (1.01 to 3.67) | 2.78 (1.10 to 7.04) | 2.09 (0.80 to 5.44) |
| • 85-89 | 0.36 (0.18 to 0.72) | 0.43 (0.20 to 0.90) | 2.69 (1.42 to 5.10) | 2.03 (1.02 to 4.02) | 3.91 (1.52 to 10.04) | 2.59 (0.96 to 6.94) |
| • ≥90 | 0.29 (0.13 to 0.66) | 0.42 (0.17 to 1.01) | 3.80 (1.86 to 7.78) | 2.70 (1.26 to 5.79) | 4.92 (1.81 to 13.32) | 3.20 (1.13 to 9.09) |
| Sex, male | 1.01 (0.70 to 1.46) | 1.08 (0.71 to 1.65) | 1.10 (0.79 to 1.53) | 1.13 (0.79 to 1.63) | 0.99 (0.65 to 1.52) | 1.22 (0.77 to 1.95) |
| Rural residence | 0.76 (0.49 to 1.17) | NA | 0.78 (0.54 to 1.13) | 0.70 (0.46 to 1.07) | 0.49 (0.29 to 0.84) | 0.52 (0.29 to 0.93) |
| No. of comorbidities | ||||||
| • 0 | 1 (Ref) | NA | 1 (Ref) | NA | 1 (Ref) | NA |
| • 1 | 0.98 (0.52 to 1.84) | NA | 0.91 (0.49 to 1.67) | NA | 1.12 (0.51 to 2.43) | NA |
| • 2 | 0.84 (0.45 to 1.57) | NA | 1.58 (0.87 to 2.86) | NA | 0.83 (0.37 to 1.84) | NA |
| • 3 | 0.60 (0.30 to 1.17) | NA | 1.82 (0.98 to 3.38) | NA | 1.58 (0.72 to 3.43) | NA |
| • ≥4 | 0.41 (0.19 to 0.88) | NA | 2.61 (1.35 to 5.03) | NA | 1.73 (0.77 to 3.91) | NA |
| In home care at baseline | 0.20 (0.12 to 0.35) | 0.30 (0.17 to 0.53) | 3.27 (2.26 to 4.74) | 2.21 (1.47 to 3.30) | 3.67 (2.36 to 5.70) | 2.91 (1.79 to 4.71) |
| ≥10 unique medications | 0.41 (0.27 to 0.62) | NA | 2.46 (1.74 to 3.47) | 2.01 (1.37 to 2.94) | 1.25 (0.81 to 1.93) | NA |
| Antidementia medications | 0.82 (0.51 to 1.32) | NA | 1.54 (1.02 to 2.32) | NA | 2.20 (1.36 to 3.56) | 1.85 (1.10 to 3.13) |
| Hospitalization in prior year | 0.35 (0.21 to 0.59) | NA | 1.54 (1.02 to 2.32) | NA | 1.06 (0.65 to 1.73) | NA |
| No. of ED visits in prior year | ||||||
| • 0 | 1 (Ref) | 1 (Ref) | 1 (Ref) | 1 (Ref) | 1 (Ref) | 1 (Ref) |
| • 1 | 0.53 (0.34 to 0.83) | 0.62 (0.38 to 1.02) | 1.47 (0.97 to 2.21) | 1.16 (0.75 to 1.81) | 1.32 (0.78 to 2.24) | 0.99 (0.57 to 1.74) |
| • 2 | 0.18 (0.07 to 0.43) | 0.22 (0.09 to 0.55) | 3.26 (1.82 to 5.83) | 2.54 (1.36 to 4.75) | 2.82 (1.51 to 5.29) | 2.38 (1.20 to 4.73) |
| • 3 | 0.20 (0.08 to 0.53) | 0.29 (0.10 to 0.79) | 1.95 (1.04 to 3.69) | 1.32 (0.66 to 2.64) | 0.94 (0.37 to 2.38) | 0.74 (0.28 to 2.00) |
| • ≥4 | 0.13 (0.04 to 0.36) | 0.16 (0.05 to 0.48) | 3.08 (1.69 to 5.61) | 2.18 (1.11 to 4.28) | 0.97 (0.42 to 2.21) | 0.80 (0.32 to 1.98) |
| Anticholinergic Risk Scale score | ||||||
| • 0 | 1 (Ref) | 1 (Ref) | 1 (Ref) | NA | 1 (Ref) | NA |
| • 1 | 0.44 (0.23 to 0.82) | 0.50 (0.25 to 1.01) | 1.63 (0.99 to 2.66) | NA | 1.33 (0.71 to 2.46) | NA |
| • 2 | 0.33 (0.12 to 0.85) | 0.30 (0.11 to 0.84) | 1.51 (0.77 to 2.94) | NA | 2.69 (1.29 to 5.63) | NA |
| • ≥3 | 0.47 (0.26 to 0.85) | 0.41 (0.21 to 0.79) | 1.49 (0.93 to 2.40) | NA | 1.18 (0.64 to 2.17) | NA |
| Provider continuity in year before baseline | ||||||
| • High (>80%) | 1 (Ref) | 1 (Ref) | 1 (Ref) | NA | 1 (Ref) | NA |
| • Medium (>50% to ≤80%) | 1.21 (0.68 to 2.14) | 1.45 (0.77 to 2.73) | 1.18 (0.72 to 1.91) | NA | 1.31 (0.69 to 2.49) | NA |
| • Low (≤50%) | 1.62 (1.02 to 2.56) | 2.03 (1.22 to 3.37) | 1.09 (0.73 to 1.62) | NA | 1.32 (0.78 to 2.25) | NA |
| • Low primary care user (<3 visits) | 1.61 (0.90 to 2.90) | 1.33 (0.70 to 2.54) | 0.81 (0.48 to 1.37) | NA | 1.83 (0.96 to 3.50) | NA |
| Social deprivation quintiles | ||||||
| • 1 (most privileged) | 1 (Ref) | NA | 1 (Ref) | NA | 1 (Ref) | NA |
| • 2 | 0.26 (0.10 to 0.66) | NA | 1.67 (0.78 to 3.59) | NA | 2.03 (0.75 to 5.51) | NA |
| • 3 | 0.53 (0.28 to 1.01) | NA | 0.97 (0.52 to 1.83) | NA | 1.16 (0.48 to 2.80) | NA |
| • 4 | 0.55 (0.29 to 1.05) | NA | 1.32 (0.71 to 2.47) | NA | 1.60 (0.68 to 3.75) | NA |
| • 5 (most deprived) | 0.52 (0.27 to 1.01) | NA | 1.00 (0.53 to 1.90) | NA | 1.00 (0.40 to 2.48) | NA |
| • Missing | 0.32 (0.13 to 0.76) | NA | 2.72 (1.26 to 5.87) | NA | 3.52 (1.37 to 9.05) | NA |
aOR—adjusted odds ratio, ED—emergency department, NA—not applicable, OR—odds ratio.
↵* Death treated as a separate outcome and full model results provided in appendix (available from CFPlus).